What is Lofstrand Labs?
Established in 1983, Lofstrand Labs Limited functions as a specialized core facility for the global scientific community. The company provides essential, labor-intensive research support, including DNA sequencing, plasmid isolation, and antibody development. By acting as an extension of busy laboratories and clinical environments, Lofstrand Labs enables researchers to focus on high-level innovation while outsourcing the technical, time-consuming aspects of basic research. Their market position is defined by a commitment to high-quality, results-driven biotechnology services that bridge the gap between raw research requirements and actionable scientific data.
How much funding has Lofstrand Labs raised?
Lofstrand Labs has raised a total of $82K across 1 funding round:
Debt
$82K
Debt (2021): $82K with participation from PPP
Key Investors in Lofstrand Labs
PPP
Public-Private Partnership
What's next for Lofstrand Labs?
With the recent influx of capital, Lofstrand Labs is expected to prioritize the expansion of its technical capabilities and laboratory infrastructure. The strategic focus will likely center on enhancing throughput for its core service offerings, such as antibody development and genomic sequencing, to accommodate a broader international client base. As the biotechnology sector continues to demand more efficient, outsourced research solutions, Lofstrand Labs is well-positioned to capture additional market share. Future growth will likely involve the integration of advanced automation technologies to further optimize their service delivery, ensuring they remain a preferred partner for laboratories seeking to maintain high standards of research integrity while managing operational costs.
See full Lofstrand Labs company page
